Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells.
Wang
Sisi
S
Division of Hematology & Oncology, Department of Internal Medicine, UC Davis Cancer Center, Sacramento, California 95817, USA.
Zhang
Hongyong
H
Malfatti
Michael
M
de Vere White
Ralph
R
Lara
Primo N
PN
Turteltaub
Kenneth
K
Henderson
Paul
P
Pan
Chong-xian
CX
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity*; D016190:Carboplatin / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry / Q000627:therapeutic use / Q000633:toxicity*; D045744:Cell Line, Tumor; D018736:DNA Adducts / Q000032:analysis* / Q000737:chemistry; D004260:DNA Repair; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D019008:Drug Resistance, Neoplasm; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*; D000093542:Gemcitabine
D018736:DNA Adducts; C096276:carboplatin-DNA adduct; D003841:Deoxycytidine; D016190:Carboplatin; D000093542:Gemcitabine